OrthoPediatrics (NASDAQ:KIDS) Trading Down 5.4% – Should You Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS) shares dropped 5.4% on Tuesday . The company traded as low as $25.09 and last traded at $25.18. Approximately 36,370 shares were traded during trading, a decline of 78% from the average daily volume of 168,215 shares. The stock had previously closed at $26.61.

Analyst Ratings Changes

Several brokerages recently commented on KIDS. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Friday, November 8th. Truist Financial cut their price target on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research note on Monday, October 14th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research note on Friday, September 13th.

OrthoPediatrics Price Performance

The firm has a market cap of $614.95 million, a PE ratio of -21.06 and a beta of 1.16. The firm’s fifty day simple moving average is $26.26 and its two-hundred day simple moving average is $29.20. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of KIDS. State Board of Administration of Florida Retirement System bought a new stake in OrthoPediatrics during the first quarter valued at about $178,000. Vanguard Group Inc. grew its position in shares of OrthoPediatrics by 1.3% during the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after purchasing an additional 11,100 shares in the last quarter. Kennedy Capital Management LLC bought a new stake in OrthoPediatrics during the 1st quarter valued at approximately $2,894,000. Alexander Labrunerie & CO. Inc. purchased a new position in OrthoPediatrics in the 1st quarter worth approximately $268,000. Finally, Harbor Capital Advisors Inc. lifted its holdings in OrthoPediatrics by 649.0% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 67,057 shares of the company’s stock worth $1,929,000 after purchasing an additional 58,104 shares in the last quarter. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.